Article info
Original research
Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer
- Correspondence to Dr Amita Kulkarni, Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Providence, Rhode Island, USA; amita.a.kulkarni.10{at}gmail.com
Citation
Frailty as a predictor of delayed initiation of adjuvant chemotherapy in patients with ovarian cancer
Publication history
- Received April 11, 2022
- Accepted November 8, 2022
- First published November 24, 2022.
Online issue publication
January 03, 2023
Article Versions
- Previous version (24 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.